Evidence map›Paper›PMID 24868283›Full record

ReviewPrzeglad gastroenterologiczny2013

Butyric acid in irritable bowel syndrome.

Andrzej Załęski, Aleksandra Banaszkiewicz, Jarosław Walkowiak

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Przeglad gastroenterologiczny, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06653426 (The Effect of Sodium Butyrate on Menstrual Symptoms in Women), which is not on this map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06653426 narecruitingnot on this mapstarted 2024, after this paper: background citation

The Effect of Sodium Butyrate on Menstrual Symptoms in Women

TypeinterventionalSponsorMagdy Milad, MDRan2024 to 2026Enrolled15ConditionsMenstrual SymptomsArmsSodium Butyrate (NaBu)
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Dietary tributyrin supplementation in Parkinson's disease: An open-label target engagement study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  9. Review
  10. Relationship of SCFAs to Maternal and Child Anthropometric Measurements.International journal of molecular sciences · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Andrzej ZałęskiDepartment of Paediatric Gastroenterology and Nutrition, Medical University of Warsaw, Poland.
Aleksandra BanaszkiewiczDepartment of Paediatric Gastroenterology and Nutrition, Medical University of Warsaw, Poland.
Jarosław WalkowiakDepartment of Paediatric Gastroenterology and Metabolic Diseases, Poznan University of Medical Sciences, Poland.
Medical University of Warsaw · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Butyric acid (butanoic acid) belongs to a group of short-chain fatty acids and is thought to play several beneficial roles in the gastrointestinal tract. Butyric anion is easily absorbed by enteric cells and used as a main source of energy. Moreover, butyric acid is an important regulator of colonocyte proliferation and apoptosis, gastrointestinal tract motility and bacterial microflora composition in addition to its involvement in many other processes including immunoregulation and anti-inflammatory activity. The pathogenesis of irritable bowel syndrome (IBS), the most commonly diagnosed functional gastrointestinal condition, is complex, and its precise mechanisms are still unclear. This article describes the potential benefits of butyric acid in IBS.

Indexed as

butyric acidirritable bowel syndromesodium butyrate

Identifiers

PMID24868283
PMCPMC4027835
OpenAlexW2081958119

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.